Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 408.18 USD 0.72% Market Closed
Market Cap: 105.1B USD
Have any thoughts about
Vertex Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Vertex Pharmaceuticals Inc

Current Assets 9.8B
Cash & Short-Term Investments 7.8B
Receivables 1.8B
Other Current Assets 243.7m
Non-Current Assets 12.4B
Long-Term Investments 4.8B
PP&E 2.5B
Intangibles 1.9B
Other Non-Current Assets 3.2B
Current Liabilities 4B
Accounts Payable 4B
Accrued Liabilities 3.2B
Other Current Liabilities -3.3B
Non-Current Liabilities 2.6B
Long-Term Debt 114m
Other Non-Current Liabilities 2.5B

Balance Sheet
Vertex Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
625
715
1 184
1 665
2 650
3 109
5 988
6 795
10 504
11 218
Cash Equivalents
625
715
1 184
1 665
2 650
3 109
5 988
6 795
10 504
11 218
Short-Term Investments
762
328
251
423
518
699
671
730
275
849
Total Receivables
76
178
204
310
415
634
885
1 137
1 442
1 563
Accounts Receivables
76
178
201
281
410
634
885
1 137
1 442
1 563
Other Receivables
0
0
3
29
5
0
0
0
0
0
Inventory
31
57
78
112
124
168
281
353
461
739
Other Current Assets
52
130
115
138
136
214
308
546
554
624
Total Current Assets
1 547
1 407
1 832
2 649
3 843
4 823
8 133
9 561
13 235
14 144
PP&E Net
716
698
698
789
812
833
1 284
1 424
1 456
1 453
PP&E Gross
0
0
698
789
812
833
1 284
1 424
1 456
1 453
Accumulated Depreciation
0
0
388
432
451
693
791
896
1 027
1 189
Intangible Assets
29
284
284
29
0
400
400
400
604
840
Goodwill
40
50
50
50
50
1 002
1 002
1 002
1 088
1 088
Note Receivable
0
30
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
20
20
0
0
21
86
99
2 596
Other Long-Term Assets
3
29
12
8
1 540
1 260
911
960
1 670
2 609
Other Assets
40
50
50
50
50
1 002
1 002
1 002
1 088
1 088
Total Assets
2 335
N/A
2 499
+7%
2 897
+16%
3 546
+22%
6 246
+76%
8 318
+33%
11 752
+41%
13 433
+14%
18 151
+35%
22 730
+25%
Liabilities
Accounts Payable
71
75
61
74
111
88
155
195
304
3 385
Accrued Liabilities
243
314
314
446
604
1 056
1 311
1 501
2 052
2 589
Short-Term Debt
0
0
300
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
32
87
19
23
10
30
42
47
41
51
Other Current Liabilities
22
31
97
265
395
161
369
400
345
543
Total Current Liabilities
368
506
793
807
1 120
1 335
1 878
2 142
2 742
3 547
Long-Term Debt
793
739
521
584
582
539
539
510
431
376
Deferred Income Tax
15
110
134
6
0
0
0
0
0
0
Minority Interest
21
154
182
14
0
0
0
0
0
0
Other Liabilities
62
49
111
106
109
360
648
681
1 065
1 226
Total Liabilities
1 260
N/A
1 559
+24%
1 740
+12%
1 517
-13%
1 811
+19%
2 233
+23%
3 065
+37%
3 333
+9%
4 238
+27%
5 150
+22%
Equity
Common Stock
2
2
2
3
3
3
3
3
3
3
Retained Earnings
4 705
5 262
5 374
5 120
2 989
1 853
859
3 201
6 523
10 142
Additional Paid In Capital
5 777
6 198
6 507
7 157
7 421
7 938
7 894
6 881
7 387
7 450
Unrealized Security Profit/Loss
0
0
18
24
1
1
0
1
0
10
Other Equity
1
2
4
36
1
2
69
16
1
24
Total Equity
1 075
N/A
940
-13%
1 157
+23%
2 029
+75%
4 435
+119%
6 085
+37%
8 687
+43%
10 100
+16%
13 913
+38%
17 580
+26%
Total Liabilities & Equity
2 335
N/A
2 499
+7%
2 897
+16%
3 546
+22%
6 246
+76%
8 318
+33%
11 752
+41%
13 433
+14%
18 151
+35%
22 730
+25%
Shares Outstanding
Common Shares Outstanding
242
246
248
253
255
259
260
254
257
258

See Also

Discover More